ARCHIVES

Michelle Le Beau named director of University of Chicago Cancer Research Center.

This article is from The Cancer Letter archive.

Vol. 30 No. 19 | May 7, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007